Jazz Pharmaceuticals plc
JAZZ
$138.81
$2.361.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 560.12M | 463.16M | 394.92M | 330.79M | 414.83M |
| Total Depreciation and Amortization | 660.07M | 650.85M | 648.18M | 644.72M | 638.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 252.44M | 228.45M | 205.98M | 229.38M | 242.92M |
| Change in Net Operating Assets | -76.72M | -177.80M | -175.96M | -166.36M | -204.44M |
| Cash from Operations | 1.40B | 1.16B | 1.07B | 1.04B | 1.09B |
| Capital Expenditure | -38.07M | -34.89M | -28.40M | -27.04M | -23.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -470.13M | -178.23M | -573.10M | -403.10M | -139.10M |
| Cash from Investing | -508.20M | -213.11M | -601.50M | -430.14M | -163.06M |
| Total Debt Issued | 980.77M | 980.77M | -- | -- | -- |
| Total Debt Repaid | -606.00M | -606.00M | -31.00M | -31.00M | -31.00M |
| Issuance of Common Stock | 20.65M | 20.30M | 25.80M | 25.73M | 46.46M |
| Repurchase of Common Stock | -369.18M | -466.59M | -391.24M | -326.74M | -320.71M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.72M | -- | -- | -- | -- |
| Cash from Financing | 20.52M | -71.52M | -396.44M | -332.02M | -305.25M |
| Foreign Exchange rate Adjustments | -1.68M | 2.40M | -1.69M | -892.00K | 1.14M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 906.55M | 882.45M | 73.50M | 275.47M | 624.83M |
